Study at a glance
How was vitamin D uptake tested with other vitamins?
The study used two separate experiments. One measured where vitamins were found in mouse intestines after dosing. The other measured uptake of vitamin combinations into human-derived intestinal cells grown in the laboratory. The cells received vitamins in prepared mixtures that kept them available in liquid. This tested one step of uptake, not complete digestion or absorption in people.
Did all vitamins reduce vitamin D uptake?
No. Added vitamin E reduced vitamin D3 uptake by about 15 to 17% at the higher tested concentrations. Vitamin A reduced it by about 30% only at the highest tested concentration. Vitamin K1 did not significantly reduce vitamin D uptake. In the reverse comparison, vitamin D reduced vitamin K1 uptake by up to about 58%. These percentages describe laboratory cell comparisons, not the amount lost from a person’s supplement.
Did eating a meal change vitamin D blood levels in human studies?
A small capsule trial found a stronger vitamin D blood response with a higher-fat meal than a lower-fat meal. A separate study using an oily solution found no significant difference between fasting and a high-fat breakfast. These trials used different preparations and comparisons. They do not prove that the preparation caused the difference, that every product needs a fatty meal, or that food never matters.
Can these experiments tell people how to take vitamin D?
Vitamin recovered inside a cell does not show how much reaches the blood or produces health benefits. The experiments did not identify one specific transport protein as the cause. Mouse groups were small, and the cell study made many comparisons without a reported overall statistical correction. The findings do not establish supplement-spacing rules, an ideal vitamin ratio or a need to increase a dose.
Read the full article below ↓Fat-soluble vitamins can interact before they reach their target tissues. A laboratory study by Goncalves and colleagues examined where vitamins accumulated along the mouse intestine and how one vitamin changed uptake of another into cultured intestinal cells. Its findings reveal selective, concentration-dependent interactions. They also show why an intestinal uptake result cannot, on its own, establish supplement timing, human vitamin D status or clinical benefit.
The experiment separates location from competition
The 2015 Food Chemistry paper contained two different investigations. One mapped vitamin content along the intestine after separate vitamin-containing emulsions were given to mice. The other placed combinations of vitamins in contact with a human-derived intestinal cell model. Keeping these experiments separate is essential: the location study did not demonstrate competition between vitamins inside a living person.
The wider physiological question belongs to Vitamin D in Nutrient Networks. Before a swallowed vitamin can act, it must be released from its preparation, remain available in the intestinal contents, enter cells and move onward. Those steps create opportunities for interaction that are different from the downstream hormonal actions usually associated with vitamin D.
A micelle is a small aggregate of digestive components that helps carry fat-soluble compounds in the watery intestinal environment. An enterocyte is an intestinal absorptive cell. The cell experiment supplied vitamins already incorporated into mixed micelles, then measured vitamin recovered from the cells. It therefore examined a controlled uptake step, rather than the complete digestion of a food or capsule.
What the mouse experiment can locate
Male mice received separate emulsions containing vitamin A, D₃, E or K₁. Investigators measured vitamin content in intestinal segments 4.5 hours later, with four mice contributing to each profile. Vitamin A was concentrated more proximally, vitamin D in the middle small intestine, and vitamins E and K more distally, including the caecum.
These are tissue-content profiles at a particular time. A high concentration in a segment could reflect entry into its cells, movement onward, local retention or the timing of delivery. It does not directly quantify the total fraction of the administered dose reaching the circulation. Nor does a relatively low tissue concentration prove that a segment contributes nothing to absorption.
The result supports further investigation of regional differences, but it is not a human anatomical map. Differences in intestinal physiology and transit matter when translating from mice. The preparation and sampling time also matter: a different formulation or an earlier observation could change where a dose is found. Vitamin D and Gut supplies the broader setting for these intestinal processes.
What the cell experiment controlled
The researchers used differentiated Caco-2 TC-7 cell monolayers, a human-derived intestinal model. Vitamins were delivered from the side corresponding to the intestinal contents. After one hour, vitamin associated with the harvested cells was measured chromatographically and related to cell protein. Results were compared with uptake of the same vitamin without the added competitor, set to 100%.
For the vitamin D comparison, the receiving vitamin was cholecalciferol at 0.5 µM. Retinol, alpha-tocopherol and phylloquinone were tested at several concentrations. Micromolar, abbreviated µM, describes concentration in the experimental fluid, not the amount in a tablet. Figures reported six to nine assays, which are laboratory observations rather than six to nine human participants.
The authors labelled their concentration ranges dietary, supplementation and pharmacological. Those labels explain the intended experimental range; they do not establish that swallowing a particular product produces the same intestinal exposure. Digestion, dilution, binding and transit separate a labelled oral dose from the concentration presented to a cell surface.
The molecular forms also differed between some experiments. Vitamin A was supplied to mice as retinyl palmitate but to the cells as retinol. The mouse vitamin E preparation used gamma-tocopherol, while the competition experiments used alpha-tocopherol. The findings should therefore be attributed to the tested forms and systems, rather than treated as identical observations across two models.
The interactions were directional
| Cell experiment | Finding and scope |
|---|---|
| Vitamin E added to vitamin D₃ | Vitamin D uptake fell about 15% and 17% at 50 and 100 µM alpha-tocopherol. |
| Vitamin A added to vitamin D₃ | Uptake fell about 30% at the highest retinol concentration, 100 µM. |
| Vitamin K₁ added to vitamin D₃ | No significant reduction in vitamin D uptake was demonstrated. |
| Vitamin D₃ added to vitamin K₁ | Vitamin K uptake fell in a concentration-dependent pattern, reaching a reduction of about 58%. |
| Vitamin E added to vitamin A | Retinol uptake increased at the two higher vitamin E concentrations. |
The vitamin K comparison is particularly important. An effect of D on K does not imply an equal or even detectable effect of K on D. The receiving vitamin and the added compound occupied different roles in the experiments. A statement that “all fat-soluble vitamins compete with vitamin D” would therefore misrepresent the reported results.
The vitamin A finding was also concentration-specific. The clear decrease in vitamin D uptake appeared at the highest tested retinol exposure, not across every tested concentration. Treating that result as proof that ordinary vitamin A-containing foods impair vitamin D absorption would erase the experimental conditions that produced the observation.
Likewise, relative uptake is not absolute bioavailability. If control cells recover a particular amount and exposed cells recover 30% less, that percentage describes the experimental comparison. It does not tell us that a person taking the combination loses 30% of their supplement, needs 30% more vitamin D, or will have a 30% lower blood concentration. Each proposed translation requires measurements at the next stage.
What might explain the pattern?
The authors considered common uptake pathways a possible explanation for some interactions. Competition is compatible with a shared transport step, but it does not identify the responsible protein. Changes in the micellar environment, compound stability or cellular handling could also influence the amount recovered. The competition experiment did not isolate a named transporter as the unique cause.
This distinction matters when connecting the findings with Vitamin D and Lipid Metabolism. Lipid handling provides a relevant physiological framework, but a framework is not a result. Demonstrating that a specific carrier explains the interaction would require an intervention that changes that carrier and alters the predicted uptake response, with appropriate controls for other changes in the cells.
The enhancement of retinol uptake by vitamin E is a further reason to avoid a single antagonism story. A combination can increase one measured uptake while decreasing another. Such asymmetry is biologically interesting and useful when designing experiments, but it cannot be reduced to a universal ranking of “helpful” and “blocking” vitamins.
How strong is the laboratory evidence?
The controlled preparations, chromatographic measurements and repeated assays support the existence of effects within the tested model. However, the mouse groups were small, and the cell experiments considered many vitamin-concentration comparisons. The paper used pairwise nonparametric testing and a conventional significance threshold; it did not describe a correction across the full family of comparisons. The patterns warrant follow-up, with particular attention to replication and effect sizes.
A cultured monolayer cannot recreate the full digestive system. It lacks an intact circulation, whole-body feedback and the ordinary variation in meals, bile delivery and transit. Measuring cell content also leaves onward export unresolved. More vitamin remaining inside a cell could mean more entry, slower exit, or both. The circulating carriers described in Vitamin D Transport Proteins belong to a further stage of tissue delivery, which this uptake experiment did not measure.
The study reported an industry-linked doctoral funding arrangement with Lesieur while declaring no conflicts of interest. This makes transparent reporting and independent replication relevant; it does not establish that the measurements are invalid. The principal limitation for a human supplement claim is the experiment’s model and endpoint, regardless of who supported the work.
Human meal trials test a different part of the question
Raimundo and colleagues’ 2011 randomised trial compared a single vitamin D₃ capsule taken with meals containing 25.6 g or 1.7 g fat. Thirty-two young adults were allocated and 30 were analysed. At day 14, mean 25-hydroxyvitamin D, or 25(OH)D, was 53.7 versus 33.7 nmol/L; the higher-fat meal produced the stronger response. The meals differed in composition as well as fat, and there was no vitamin D-free placebo group.
This is human evidence about a meal-associated response to a particular preparation. It is not evidence about combining vitamins A, D, E and K. It also measured a metabolite days later, rather than tracing the fraction of the dose crossing the intestine. Differences in measured 25(OH)D can be consistent with altered absorption without being a direct measurement of absorption alone.
Cavalier and colleagues’ 2016 crossover provides a useful contrast. Eighty-eight healthy adults took 50,000 IU vitamin D₃ in an oily solution both fasting and with a high-fat breakfast, on occasions separated by 60 days. All completed both periods. The investigators did not detect a significant meal-related difference in the 25(OH)D₃ response at the reported early follow-up visits or in their cumulative response analysis. Day-14 means were approximately 25.6 and 25.7 ng/mL.
That study selected participants with a restricted starting vitamin D range and a body mass index between 18 and 25. It was open-label, sponsored by the preparation’s manufacturer, and used a different preparation and comparison from the earlier capsule experiment. Its analysis used a 2.5% threshold for one-tailed tests. The absence of a detected meal effect in that setting is not proof that food never matters or a formal demonstration of equivalence. Equally, the earlier positive result does not prove that every formulation requires a high-fat meal.
These studies help explain Why Vitamin D Studies Disagree without assuming that one must be wrong. Formulation, participant selection, comparator and sampling schedule can change the experimental question. Oil delivery is one possible contributor to the different findings, but the studies did not randomise people directly between those two trials’ formulations under otherwise identical conditions. It therefore remains an explanation to test rather than an established cause of the difference.
Where uptake sits between diet and biological effect
The broader dietary context is covered in Diet Patterns and Vitamin D Context. Foods bring several nutrients and physical structures together; a cell culture receives a deliberately simplified mixture. That simplification helps isolate a question, while removing parts of everyday digestion that could change the answer. Neither level should be presented as a complete substitute for the other.
After absorption, distribution and Vitamin D Storage can alter how a dose appears in the circulation over time. Conversion to metabolites introduces further variation. Consequently, a better one-hour uptake result does not necessarily mean a larger sustained 25(OH)D rise, and a larger blood rise does not by itself establish greater clinical benefit. Vitamin D Response considers the broader distinction between an administered dose and the response observed in a person.
The calcium-response experiment discussed in Vitamin A and the Calcium Response to Calcitriol: Full Study takes place at another level again: it administered active calcitriol and assessed blood chemistry. Its vitamin A finding cannot supply the missing human validation for the cell-uptake result. Together, the papers identify more than one possible interaction site, without showing that the same mechanism explains both observations.
What follows for supplement timing and future research?
The experiments justify testing whether particular formulations and combinations alter human exposure. They do not provide a validated timetable for separating vitamins, a minimum number of hours between doses, or an optimal A:D:E:K ratio. A timing recommendation would require a human comparison of simultaneous and separated administration, using the intended products and measuring a meaningful outcome.
Such a study would need to distinguish early circulating cholecalciferol from later 25(OH)D, record the meal and formulation, and assess whether any difference persists with repeated use. If a clinical benefit is claimed, the clinical outcome also needs measurement. Otherwise an improvement in a laboratory uptake percentage could be promoted far beyond what was tested.
The defensible conclusion is that fat-soluble vitamin interactions can be selective and concentration-dependent at an intestinal uptake step. Mouse profiles suggest regional differences, while human meal trials show that preparation and context matter. The evidence supports careful formulation research; it does not establish universal supplement-separation advice. Fat-Soluble Vitamins and Intestinal Vitamin D Uptake: Study Summary provides the shorter account of the findings and their limits.
Primary source and publication details
Related reading
A Case-Control Study of the Association between Vitamin D Levels and Gastric Incomplete Intestinal Metaplasia
Low circulating vitamin D levels are associated with gastric adenocarcinoma, but whether vitamin D levels are associated with premalignant gastric mucosal changes is unknown.
Original paper ↗Read more →A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation
The objective of this study was to evaluate if there is a food effect on absorption when a high dose of vitamin D3 is completely solubilized in an oily solution.
Original paper ↗Read more →Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases
Vitamin D, a crucial fat-soluble vitamin, is primarily synthesized in the skin upon exposure to ultraviolet radiation and is widely recognized as a bone-associated hormone.
Original paper ↗Read more →Dynamic alterations in metabolomics and transcriptomics associated with intestinal fibrosis in a 2,4,6-trinitrobenzene sulfonic acid-induced murine model
In this study, we aimed to investigate the relationship between the development of intestinal fibrosis and the dynamic alterations in both fecal metabolites and host gene expression.
Original paper ↗Read more →Effect of dietary nonphytate phosphorus on laying performance and small intestinal epithelial phosphate transporter expression in Dwarf pink-shell laying hens
This study examined the effects of various levels of dietary nonphytate phosphorus on laying performance and the expression patterns of phosphorus metabolism related genes in Dwarf pink-shell laying hens.
Original paper ↗Read more →Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis
The aim of the study was to evaluate the vitamin status and metabolic profile before and after the supplementation of fat-soluble vitamins A, D, E and K (ADEK) in 51 patients with fat malabsorption due to different intestinal diseases both with and without urolithiasis.
Original paper ↗Read more →Effect of High: versus Low-Fat Meal on Serum 25-Hydroxyvitamin D Levels after a Single Oral Dose of Vitamin D: A Single-Blind, Parallel, Randomized Trial
Our aim was to compare serum 25-hydroxyvitamin D [25(OH)D] after the oral intake of cholecalciferol with a high: or low-fat meal.
Original paper ↗Read more →Effects of Formula Product Injection on Hatching Parameters, Small Intestinal Development and Ileum Histology in Breeder Chicken Eggs
This study aimed to determine the effects of in ovo formula product injection on hatching parameters, chick quality, small intestinal development and ileum histology of breeder hen eggs.
Original paper ↗Read more →Fat and vitamin intakes during pregnancy have stronger relations with a pro-inflammatory maternal microbiota than does carbohydrate intake
Although diet is known to have a major modulatory influence on gut microbiota, knowledge of the specific roles of particular vitamins, minerals, and other nutrients is limited.
Original paper ↗Read more →Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature
Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of lymphatic fluids into the intestinal lumen, causing depletion of lymphocytes, protein, lipids, fat-soluble vitamins, and electrolytes.
Original paper ↗Read more →Identification of trans-genus biomarkers for early diagnosis of intestinal schistosomiasis and progression of gut pathology in a mouse model using metabolomics
Therefore, we aimed to identify early gut biomarkers of infection with three Schistosoma spp.
Original paper ↗Read more →Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
However, few studies have investigated the incidence and risk factors for micronutrient deficiency.
Original paper ↗Read more →Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice
Bariatric surgeries such as the Vertical Sleeve Gastrectomy (VSG) are invasive but provide the most effective improvements in obesity and Type 2 diabetes.
Original paper ↗Read more →Metabolic Bone Disease in Children with Intestinal Failure and Long-Term Parenteral Nutrition: A Systematic Review
The aim of this systematic review was to define the prevalence of MBD in IF children and to describe risk factors for its development.
Original paper ↗Read more →Molar incisor hypomineralisation in relation to fat-soluble vitamin status and intestinal permeability in children with celiac disease
Celiac disease (CD) is a systemic autoimmune enteropathy triggered by gluten ingestion that frequently manifests with extra-intestinal complications, including enamel defects.
Original paper ↗Read more →Organic Synthesis of New Secosteroids from Fucosterol, Its Intestinal Absorption by Caco-2 Cells, and Simulation of the Biological Activities of Vitamin D
We investigated the intestinal absorption of these compounds using Caco-2 cells cultured in Transwells and compared the results with vitamin D3, a representative secosteroid.
Original paper ↗Read more →Plasma fat-soluble vitamin and carotenoid concentrations after plant sterol and plant stanol consumption: a meta-analysis of randomized controlled trials
Forty-one randomized controlled trials involving 3306 subjects were included.
Original paper ↗Read more →Recommendations for dietary level of micro-minerals and vitamin D3 to Atlantic salmon (Salmo salar) parr and post-smolt when fed low fish meal diets
Micro-nutrients, namely Zn, Mn, Se, Cu, Fe, Co, I and vitamin D3 were included in the NP with the objective of (re)evaluating the dietary need to meet the requirement of Atlantic salmon parr and post-smolt, when fed low fish meal, plant ingredient-based diets.
Original paper ↗Read more →The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing
All participants gave their informed consent to participate in the study.
Original paper ↗Read more →Vitamin D Receptor Protects against Radiation-Induced Intestinal Injury in Mice via Inhibition of Intestinal Crypt Stem/Progenitor Cell Apoptosis
This study investigated whether VDR could inhibit IR-induced intestinal injury and explored underlying mechanism.
Original paper ↗Read more →Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis
Subsequently, we investigated p53 upregulated modulator of apoptosis (PUMA) and p53, two major independent pathways of apoptosis, as well as caspase-3.
Original paper ↗Read more →Original sources
Fat-soluble vitamin intestinal absorption: Absorption sites in the intestine and interactions for absorption
Published in Food Chemistry (2015).
Publication details
Goncalves A, Roi S, Nowicki M, Dhaussy A, Huertas A, Amiot MJ, Reboul E. Fat-soluble vitamin intestinal absorption: Absorption sites in the intestine and interactions for absorption. Food Chemistry. 2015;172:155 to 160. DOI: 10.1016/j.foodchem.2014.09.021. PMID: 25442537. Published-article PDF.
Effect of High- versus Low-Fat Meal on Serum 25-Hydroxyvitamin D Levels after a Single Oral Dose of Vitamin D: A Single-Blind, Parallel, Randomized Trial
Published in International Journal of Endocrinology (2011).
Publication details
Raimundo FV, Faulhaber GAM, Menegatti PK, Marques LS, Furlanetto TW. Effect of High: versus Low-Fat Meal on Serum 25-Hydroxyvitamin D Levels after a Single Oral Dose of Vitamin D: A Single-Blind, Parallel, Randomized Trial. International Journal of Endocrinology. 2011;2011:809069. DOI: 10.1155/2011/809069. PMID: 22190928.
A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation
Published in Nutrients (2016).
Publication details
Cavalier E and colleagues. A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation. Nutrients. 2016;8:309. DOI: 10.3390/nu8050309. PMID: 27213447.
Vitamin A Antagonizes Calcium Response to Vitamin D in Man
Published in Journal of Bone and Mineral Research (2001).
Publication details
Johansson S, Melhus H. Vitamin A Antagonizes Calcium Response to Vitamin D in Man. Journal of Bone and Mineral Research. 2001;16:1899 to 1905. DOI: 10.1359/jbmr.2001.16.10.1899. PMID: 11585356.